Sarah McBride, set to be the first transgender member of Congress, talked with CBS News' Scott MacFarlane and commented on ...
Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...